A preclinical study in mice has revealed that a specific miRNA could target and modulate the gut microbiome with precision, holding potential as a new treatment option for multiple sclerosis.
Scientists reveal that a molecule normally used by the immune system to prevent excessive damage may actually contribute to chronic white matter injury.
New research reveals that individuals exposed to more of the sun’s rays, particularly in their youth, are less likely to go on to develop multiple sclerosis.
Researchers have demonstrated significant reductions in levels of fatigue for multiple sclerosis patients in a randomized trial assessing transcranial direct current stimulation.
Novel research adds further evidence to the argument that resistance training is not futile for multiple sclerosis patients.
Researchers have found the first evidence that autoimmunity plays a role in Parkinson’s disease, showing that T cells recognize α-synuclein peptides.
Autoantibodies occur in many different nervous system disorders, and are increasingly being found in disorders not traditionally associated with the immune system. Determining if the autoantibodies play a functional or pathogenic role is critical in selecting the most appropriate treatment options.
Milan Fiala and Matteo Pellegrini review current research that indicates a role for omega-3 fatty acids in slowing the progression of mild cognitive impairment.
In this edition of NCTalks, we speak to Robyn Klein as part of our Spotlight on neuroimmunology – Robyn discusses her research, how inflammatory processes contribute to neurologic disease, and whether immunology and inflammation could be the basis of an eventual preventative treatment for neurodegenerative disease.
Karmakar & Reilly review what is known about the role of NF1 mutation in immune cell function & the role of immune cells in promoting tumorigenesis in NF1.